CoChat

Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions

Chait, Alan, Goldberg, Ira · 2017 · Current Diabetes Reports

The DOI matches its Crossref record; 111 of the 113 references it cites were found in a registry or an index.

Abstract

Purpose of review This article reviews current knowledge concerning diabetic dyslipidemia and cardiovascular disease (CVD). It reviews strategies to reduce diabetes-associated CVD, including reducing low-density lipoprotein levels, lowering triglycerides, and increasing high-density lipoproteins (HDL). Special considerations, such as the multifactorial chylomicronemia syndrome and partial lipodystrophy, and the role of glucose-lowering strategies in the management of diabetic dyslipidemia are discussed.Recent findings The strongest evidence to date for reducing CVD in diabetes comes from the use of statins. While triglyceride lowering remains inconclusive, an ongoing trial might provide some finality to this question. The role of increasing HDL remains elusive, and HDL cholesterol appears to be an unsatisfactory metric for monitoring therapy. The use of statins offers the best current way to reduce diabetes-associated CVD. However, several novel and promising approaches for the management of diabetic dyslipidemia aimed at reducing CVD are in the pipeline.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11892-017-0942-8

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 111 references

Research works printed but not linked: 2

  1. Purnell JQ, Hokanson JE, Marcovina SM, Cleary PA, Steffes MW, Brunzell JD. Weight gain accompanying intensive diabetes therapy in type 1 diabetes is associated with higher levels of dense LDL cholesterol. JInvestMed. 1996;44:180A.
  2. Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PHR, Purnell JQ, et al. The contribution of intra-abdominal fat to gender differences in hepatic lipase activity and LDL/HDL heterogeneity. J Clin Endo Metab. 2001;86:2831–7.

Cited by

See all 43

Metadata

Authors
Chait, A., & Goldberg, I.
Affiliations
  • University of Washington (US)
  • New York University (US)
Corresponding author
Chait, Alan
Venue
Current Diabetes Reports
Published
2017-09-27
Volume
17
Issue
11
Pages
112-112
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
OpenAlex
W2757879724
Cited by
40
References
113
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 8 · 2019: 4 · 2018: 7
FWCI
1.10
Type
journal article
Language
en
Open access
closed
Locations
  • Current Diabetes Reports (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (P01HL092969)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
diabetic dyslipidemia, cardiovascular disease in diabetes, statins, LDL cholesterol lowering, triglyceride lowering, HDL cholesterol, partial lipodystrophy, glucose-lowering therapy, lipid-lowering therapy
MeSH terms
Hypolipidemic Agents, Blood Glucose, Diabetes Mellitus, Humans, Lipids, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions. https://app.cochat.ai/papers/10.1007/s11892-017-0942-8
The paper
Chait, A., & Goldberg, I. (2017). Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions. Current Diabetes Reports. https://doi.org/10.1007/s11892-017-0942-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.